Tiedemann Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $392K | Sell |
4,314
-90
| -2% | -$8.19K | 0.02% | 188 |
|
|
2023
Q2 | $356K | Buy |
4,404
+90
| +2% | +$7.28K | 0.02% | 190 |
|
|
2023
Q1 | $346K | Sell |
4,314
-6
| -0.1% | -$481 | 0.02% | 194 |
|
|
2022
Q4 | $292K | Hold |
4,320
| – | – | 0.01% | 198 |
|
|
2022
Q3 | $215K | Hold |
4,320
| – | – | 0.01% | 209 |
|
|
2022
Q2 | $241K | Sell |
4,320
-5,678
| -57% | -$317K | 0.02% | 198 |
|
|
2022
Q1 | $560K | Sell |
9,998
-2
| -0% | -$112 | 0.03% | 180 |
|
|
2021
Q4 | $560K | Sell |
10,000
-550
| -5% | -$30.8K | 0.03% | 182 |
|
|
2021
Q3 | $506K | Sell |
10,550
-574
| -5% | -$27.5K | 0.03% | 190 |
|
|
2021
Q2 | $466K | Sell |
11,124
-294
| -3% | -$12.3K | 0.02% | 238 |
|
|
2021
Q1 | $391K | Buy |
11,418
+1,134
| +11% | +$38.8K | 0.02% | 238 |
|
|
2020
Q4 | $359K | Sell |
10,284
-90
| -0.9% | -$3.14K | 0.02% | 235 |
|
|
2020
Q3 | $360K | Hold |
10,374
| – | – | 0.02% | 247 |
|
|
2020
Q2 | $339K | Sell |
10,374
-688
| -6% | -$22.5K | 0.02% | 238 |
|
|
2020
Q1 | $337K | Buy |
11,062
+330
| +3% | +$10.1K | 0.02% | 229 |
|
|
2019
Q4 | $311K | Sell |
10,732
-1,434
| -12% | -$41.6K | 0.01% | 241 |
|
|
2019
Q3 | $315K | Sell |
12,166
-1,540
| -11% | -$39.9K | 0.02% | 255 |
|
|
2019
Q2 | $350K | Buy |
13,706
+804
| +6% | +$20.5K | 0.02% | 233 |
|
|
2019
Q1 | $342K | Hold |
12,902
| – | – | 0.02% | 346 |
|
|
2018
Q4 | $298K | Buy |
12,902
+1,578
| +14% | +$36.4K | 0.02% | 347 |
|
|
2018
Q3 | $267K | Hold |
11,324
| – | – | 0.02% | 269 |
|
|
2018
Q2 | $262K | Buy |
11,324
+334
| +3% | +$7.73K | 0.02% | 260 |
|
|
2018
Q1 | $271K | Buy |
+10,990
| New | +$271K | 0.02% | 234 |
|